Use of ErbB-1 and ErbB-2 to Select Endocrine Therapy for Breast Cancer: Will It Play in Peoria?
Academic Article
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- September 15, 2001
has subject area
- 1112 Oncology and Carcinogenesis (FoR)
- Antineoplastic Agents (MeSH)
- Breast Neoplasms (MeSH)
- ErbB Receptors (MeSH)
- Estrogen Antagonists (MeSH)
- Female (MeSH)
- Humans (MeSH)
- Letrozole (MeSH)
- Neoadjuvant Therapy (MeSH)
- Nitriles (MeSH)
- Oncology & Carcinogenesis (Science Metrix)
- Predictive Value of Tests (MeSH)
- Receptor, Epidermal Growth Factor (MeSH)
- Receptor, ErbB-2 (MeSH)
- Tamoxifen (MeSH)
- Triazoles (MeSH)
published in
- Journal of Clinical Oncology Journal